CapsoVision, Inc Common Stock

CapsoVision, Inc Common Stock

Yahoo Finance • 15 days ago

CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission

Earnings Call Insights: CapsoVision, Inc. (CV) Q2 2026 MANAGEMENT VIEW * “The second quarter represented another period of steady progress for CapsoVision as we continued executing our commercial strategy while advancing several import... Full story

Yahoo Finance • 15 days ago

CapsoVision, Inc. GAAP EPS of -$0.15 misses by $0.02, revenue of $3.64M misses by $0.17M

* CapsoVision, Inc. press release [https://seekingalpha.com/pr/20619065-capsovision-reports-second-quarter-2026-financial-results] (CV [https://seekingalpha.com/symbol/CV]): Q2 GAAP EPS of -$0.15 misses by $0.02. * Revenue of $3.64M (+... Full story

Yahoo Finance • last month

Visteon Announces Second Quarter 2026 Financial Results and $200 Million Accelerated Share Repurchase Program

VAN BUREN TOWNSHIP, Mich., July 23, 2026 /PRNewswire/ -- Visteon Corporation (NASDAQ: VC) today reported second quarter financial results. Highlights include:Visteon Logo Sales of $960 million with Growth-over-Market of 4%1 Net income att... Full story

Yahoo Finance • 2 months ago

CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors

SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, announced the appointment of David... Full story

Yahoo Finance • 3 months ago

CapsoVision expects AI-assisted reading clearance around midyear, with CapsoCam Colon Gen 2 imaging and AI module targeted for Q3 2026

Earnings Call Insights: CapsoVision (CV) Q1 2026 MANAGEMENT VIEW * "CapsoVision remains focused on advancing earlier, more accurate and more accessible detection of gastrointestinal disease for patients worldwide," said Co-Founder, Pre... Full story

Yahoo Finance • 3 months ago

CapsoVision, Inc. GAAP EPS of -$0.15 misses by $0.02, revenue of $2.8M misses by $0.18M

* CapsoVision, Inc. press release [https://seekingalpha.com/pr/20516432-capsovision-reports-first-quarter-2026-financial-results] (CV [https://seekingalpha.com/symbol/CV]): Q1 GAAP EPS of -$0.15 misses by $0.02. * Revenue of $2.8M miss... Full story

Yahoo Finance • 5 months ago

Benchmark updates its best ideas list

[Close Up Image Of A Stock Market Graph] solarseven/iStock via Getty Images Benchmark Equity Research on Tuesday released its quarterly update to the firm’s “best ideas” list, featuring 29 high-conviction, catalyst-driven stock picks sele... Full story

Yahoo Finance • 5 months ago

CapsoVision Announces $14 Million Private Placement Financing

SARATOGA, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (the “Company”) (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced th... Full story

Yahoo Finance • 9 months ago

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference

SARATOGA, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, P... Full story

Yahoo Finance • 9 months ago

CapsoVision Reports Third Quarter 2025 Financial Results

CapsoVision SARATOGA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial... Full story

Yahoo Finance • 10 months ago

CapsoVision Appoints David Garcia as Senior Vice President of Finance

CapsoVision Seasoned finance executive brings public company, capital markets and transaction experience to support next phase of growth SARATOGA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-sta... Full story

Yahoo Finance • 10 months ago

CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025

SARATOGA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the company wi... Full story

Yahoo Finance • 11 months ago

ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City

NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025, at the Metropolitan... Full story

Yahoo Finance • 11 months ago

CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

SARATOGA, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang,... Full story

Yahoo Finance • last year

CapsoVision GAAP EPS of -$2.02 misses by $1.91, revenue of $3.32M beats by $0.07M

* CapsoVision, Inc. press release [https://seekingalpha.com/pr/20201913-capsovision-reports-second-quarter-2025-financial-results] (NASDAQ:CV [https://seekingalpha.com/symbol/CV]): Q2 GAAP EPS of -$2.02 misses by $1.91. * Revenue of $3... Full story

Yahoo Finance • last year

Smart Pills Company Evaluation Report 2025 | Medtronic, Olympus, and CapsoVision Lead with Minimally Invasive and AI-Enhanced Medical Technologies

Company Logo The 360 Quadrants analysis highlights the leaders in the global Smart Pills market, evaluating over 102 companies. Smart pills, also known as ingestible sensors or digital pills, offer revolutionary diagnostic functions and m... Full story